**Chemours Shares Surge Following EPA Settlement**
Chemours (CC) saw a 6.1% increase in shares, closing at $21.17 after reaching a comprehensive settlement with the U.S. EPA regarding PFAS-related claims. This settlement alleviates significant regulatory concerns and was announced in the latest trading session. The company had previously experienced a 9.7% decline over the last four weeks.
For the upcoming quarterly earnings report, Chemours is expected to post earnings of $0.39 per share, reflecting a year-over-year decrease of 32.8%, with revenues anticipated at $1.65 billion, a 1.9% increase from the prior year. The consensus EPS estimate has remained stable for the last 30 days, emphasizing the importance of monitoring future earnings trends for ongoing stock performance.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
